A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NA_IVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER

被引：0
|
作者：
Patel, Sunil H.
Gabrielson, Andrew T.
Chan, Sin
Schwartz, Deborah
Collins, Connie
Singla, Nirmish
Trock, Bruce
Bivalacqua, Trinity J.
Hahn, Noah
Kates, Max R.
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
10.1097/01.JU.0001008640.01272.9d.14
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP16-14
引用
收藏
页码：E245 / E246
页数：2
相关论文
共 50 条
  • [21] Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer
    Kyla N. Velaer
    Ryan L. Steinberg
    Lewis J. Thomas
    Michael A. O’Donnell
    Kenneth G. Nepple
    Current Urology Reports, 2016, 17
  • [22] Phase II trial of intravesical camrelizumab in BCG-unresponsive high-risk non-muscle invasive bladder cancer
    Shen, Yijun
    Peng, Liangju
    Xu, Peihang
    Wang, Yanhao
    Wang, Xiang
    Yao Xudong
    Liu, Yushan
    Ye, Ding-Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Early Experience with Intravesical Gemcitabine-Docetaxel for BCG-Nayve Patients with High Grade Non-Muscle Invasive Bladder Cancer
    Babajide, R.
    Labbate, C.
    Saoud, R.
    Agarwal, P. K.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 901 - 901
  • [24] A Phase 2 Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guérin-Naïve Nonmuscle-Invasive Urothelial Carcinoma of the Bladder
    Patel, Sunil H.
    Gabrielson, Andrew T.
    Chan, Sin
    Schwartz, Deborah
    Collins, Connie
    Singla, Nirmish
    Trock, Bruce
    Bivalacqua, Trinity J.
    Hahn, Noah
    Kates, Max R.
    JOURNAL OF UROLOGY, 2024, 212 (01): : 95 - 103
  • [25] Phase II trial of intravesical gemcitabine in BCG refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Mazumdar, M
    Russo, P
    Sheinfeld, J
    Donat, SM
    Bochner, BH
    Herr, HW
    Sogani, P
    Ginty, J
    Bajorin, DF
    JOURNAL OF UROLOGY, 2004, 171 (04): : 72 - 72
  • [26] Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer
    Chakra, Mohamad Abou
    Mcelree, Ian M.
    Packiam, Vignesh T.
    Mott, Sarah L.
    O'Donnell, Michael A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (09) : 289e13 - 289e21
  • [27] The comparison of different BCG strains in the intravesical treatment of non-muscle invasive urothelial carcinoma of urinary bladder-A real-world practice
    Chen, Yu-Kuang
    Huang, Eric Yi-Hsiu
    Chang, Yen-Hwa
    Kuo, Junne-Yih
    Chung, Hsiao-Jen
    Wu, Howard Hung-Hao
    Lin, Tzu-Ping
    Lin, Chih-Chieh
    Fan, Yu-Hua
    Huang, I-Shen
    Lin, Alex T. L.
    Huang, William J.
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (09) : 928 - 934
  • [28] INTRAVESICAL GEMCITABINE FOR NON-MUSCLE INVASIVE BLADDER CANCER: A COCHRANE REVIEW
    Hwang, Eu Chang
    Maisch, Philipp
    Jung, Jae Hung
    Narayan, Vikram
    Cleves, Anne
    Dahm, Philipp
    JOURNAL OF UROLOGY, 2020, 203 : E1127 - E1127
  • [29] The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience
    Barlow, LaMont J.
    McKiernan, James M.
    Benson, Mitchell C.
    WORLD JOURNAL OF UROLOGY, 2009, 27 (03) : 331 - 335
  • [30] The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience
    LaMont J. Barlow
    James M. McKiernan
    Mitchell C. Benson
    World Journal of Urology, 2009, 27 : 331 - 335
12345